Lilly Oncology On Canvas Celebrates 10 Years of Cancer Journeys - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Lilly Oncology On Canvas Celebrates 10 Years of Cancer Journeys


PTSM: Pharmaceutical Technology Sourcing and Management
Volume 10, Issue 6

Participants at the American Society of Clinical Oncology's (ASCO) Annual Meeting in Chicago were invited to mark National Cancer Survivor's Day on June 1 through artistic expression and help create a mural of a caregiver's artistic interpretation of her sister's journey with lung cancer.

The Hope Murals Project marks the 10th anniversary of the Lilly Oncology On Canvas Art Competition, which invites residents of the US and Puerto Rico who have been affected by cancer to express, through art and narrative, the meaning of their cancer journeys. The Hope Murals Project brings 10 murals based on art from past competitions to 10 cities across the US and Puerto Rico.

Marking the official launch of The Hope Murals Project, oncology professionals came together at ASCO to create the mural using a "paint-by-number" process. The subject of the mural painted at ASCO is "Creating a New Universe," a 2010 Oncology On Canvas competition entry by Chicago resident Gloria Cichy.

Each of the 10 works to be transformed into Hope Murals is chosen through public vote on the Lilly Oncology On Canvas Facebook page. The first mural was completed in Anaheim, CA, by attendees of the Oncology Nursing Society's 39th Annual Congress, and was permanently installed at the Anaheim Central Library.

Source: Lilly Oncology On Canvas Art Competition

ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
What role should the US government play in the current Ebola outbreak?
Finance development of drugs to treat/prevent disease.
Oversee medical treatment of patients in the US.
Provide treatment for patients globally.
All of the above.
No government involvement in patient treatment or drug development.
Finance development of drugs to treat/prevent disease.
23%
Oversee medical treatment of patients in the US.
14%
Provide treatment for patients globally.
7%
All of the above.
47%
No government involvement in patient treatment or drug development.
9%
Jim Miller Outsourcing Outlook Jim MillerOutside Looking In
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerAdvances in Large-Scale Heterocyclic Synthesis
Jill Wechsler Regulatory Watch Jill Wechsler New Era for Generic Drugs
Sean Milmo European Regulatory WatchSean MilmoTackling Drug Shortages
New Congress to Tackle Health Reform, Biomedical Innovation, Tax Policy
Combination Products Challenge Biopharma Manufacturers
Seven Steps to Solving Tabletting and Tooling ProblemsStep 1: Clean
Legislators Urge Added Incentives for Ebola Drug Development
FDA Reorganization to Promote Drug Quality
Source: PTSM: Pharmaceutical Technology Sourcing and Management,
Click here